ArticleBMC microbiology2026
Genomic perspectives on the global dissemination of Elizabethkingia anophelis: unveiling inherent multidrug resistance and virulence determinants.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: A neonatal case ofFrontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundElizabethkingia anophelis has emerged as a formidable pathogen responsible for severe, life-threatening infections in immunocompromised populations. However, the genetic underpinnings of its virulence and antimicrobial resistance remain poorly characterized. Leveraging our previously assembled collection of 197 E. anophelis isolates with complete genome sequences, we performed an exhaustive, large-scale comparative analysis across global datasets to systematically map resistance determinants and virulence factors. Additionally, we constructed an integrated coexpression network to elucidate genotype-phenotype correlations in antibiotic resistance patterns.
resultsThe distribution of virulence-associated genes displays moderate phylogenetic specificity, exhibiting constrained variation within established primary clades. Importantly, virulence gene profiles demonstrate little discernible association with specimen source, sample category, or geographic origin. Although diverse antimicrobial resistance genotypes were detected, these exhibited negligible lineage specificity with minimal differentiation among core phylogenetic clusters. Coexpression network analysis suggests that E. anophelis resistance to cephalosporins, carbapenems, and aztreonam primarily arises from the constitutive expression of chromosomally encoded resistance determinants. In contrast, these chromosomally encoded resistance mechanisms appear to exert either negligible or clinically insignificant effects on susceptibility patterns for the remaining fourteen tested antimicrobial agents.
conclusionsThis study demonstrates that the multidrug resistance and pathogenic potential of E. anophelis are predominantly intrinsic traits, regulated by complex, multilayered biological mechanisms. Comprehensive elucidation of the bacterium’s virulence and resistance pathways necessitates the discovery of novel molecular targets followed by systematic, in-depth characterization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.